<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01679145</url>
  </required_header>
  <id_info>
    <org_study_id>HE2597/141;ZI1119/31;WI709/101</org_study_id>
    <nct_id>NCT01679145</nct_id>
  </id_info>
  <brief_title>Learning and Relapse Risk in Alcohol Dependence</brief_title>
  <acronym>LeAD</acronym>
  <official_title>Learning Mechanisms as Predictors of Treatment Outcome in Alcohol- Dependent Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Carl Gustav Carus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Technische Universität Dresden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to assess which behavioral and neuroimaging alterations associated
      with reward- based learning predict relapse in alcohol- dependent patients within a follow-
      up period of 12 months.

      The investigators will explore how these alterations interact with clinical and psychosocial
      factors which can modify the relapse risk. Functional magnetic resonance imaging (fMRI) and
      positron emission tomography (PET) will be used to identify neurofunctional abnormalities in
      neurotransmitter systems. The investigators will also provide data for genetic analysis and
      modeling.

      Patients will be detoxified in an inpatient setting and followed for 12 months using the
      Time-Line Follow- Back Procedure. Clinical assessments, behavioral paradigms of learning and
      brain imaging will be carried out within at least 4 half- lives after any psychotropic
      medication.

      The investigators will implement and apply functional imaging paradigms assessing
      Pavlovian-to-instrumental transfer and reversal learning tasks and associate model parameters
      of learning with alcohol craving, intake and prospective relapse risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project will examine 150 detoxified alcohol-dependent patients and 100 age- and gender
      matched controls. The main aim of this project is to assess 1) which behavioural and
      neuroimaging alterations (fMRI) associated with reward-based learning (see Projects 1 &amp; 3)
      predict relapse within the follow-up period of 6 months, 2) how these interact with clinical
      and psychosocial factors which can modify the relapse risk, and 3) to provide data for
      genetic and imaging analyses and modelling. Furthermore, we will explore gender effects on
      functional imaging parameters of learning. Patients will be detoxified in an inpatient
      setting and followed for 6 months using the Form 90 and Time-Line Follow-Back Procedure.
      Clinical assessments, behavioral paradigms of learning, and brain imaging will be carried out
      within at least 4 half-lives after any psychotropic medication. Subjects will undergo medical
      management with bimonthly follow-ups and predefined in- and exclusion criteria as described
      previously. We will implement and apply functional imaging paradigms assessing
      Pavlovian-to-instrumental transfer and reversal learning as described in Projects 1 and 3. We
      will associate model parameters of learning with alcohol craving, intake and prospective
      relapse risk. Independent of these central questions, we will also assess comorbidity,
      psychosocial and neurobiological disease severity markers to control for specificity of
      findings.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>blood oxygenation level dependent (BOLD) response</measure>
    <time_frame>first assessment time point (alc. dependent pat. up to 21 days after detoxification)</time_frame>
    <description>investigation of neuronal activation of the mesolimbic system in alcohol-dependent patients and healthy controls using 3 Tesla magnetic resonance imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment response</measure>
    <time_frame>12-month follow-up period beginning after first assessment timepoint</time_frame>
    <description>test the predictive effects of learning parameters and related neuronal correlates for treatment outcome (relapse vs abstinence) in alcohol-dependent patients</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">225</enrollment>
  <condition>Alcohol Use Disorders</condition>
  <arm_group>
    <arm_group_label>Alcohol- dependent patients</arm_group_label>
    <description>Detoxified alcohol- dependent patients in an inpatient setting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Age- and gender matched healthy controls</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      liver encymes
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Detoxified alcohol- dependent patients and age- and gender matched healthy controls living
        in Germany
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Alcohol dependence according to DSM-IV

          -  Minimum of 72 hours of abstinence, maximum of 21 days of abstinence

          -  Minimum of three years of alcohol dependence

          -  Low severity of withdrawal symptoms

          -  Ability to provide fully informed consent and to use self- rating scales

        Exclusion Criteria:

          -  Lifetime history of DSM- IV bipolar or psychotic disorder

          -  Current threshold DSM-IV diagnosis of any following disorders: current major -
             depressive disorder, generalized anxiety disorder, PTSD, borderline personality
             disorder or obsessive- compulsive disorder

          -  History of substance dependence other than alcohol or nicotine dependence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Heinz, Prof MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrich S Zimmermann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Carl Gustav Carus, Dresden, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andreas Heinz, Prof MD</last_name>
    <role>Study Chair</role>
    <affiliation>Charité University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans-Ulrich Wittchen, Prof PhD</last_name>
    <role>Study Director</role>
    <affiliation>Technische Universität Dresden, Dresden, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Technische Universität Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>01187</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Carl Gustav Carus at the Technische Universitaet Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://lead-studie.de/</url>
    <description>Official study group website</description>
  </link>
  <link>
    <url>http://gepris.dfg.de/gepris/projekt/209290463</url>
    <description>English study description</description>
  </link>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2012</study_first_submitted>
  <study_first_submitted_qc>September 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2012</study_first_posted>
  <last_update_submitted>July 27, 2016</last_update_submitted>
  <last_update_submitted_qc>July 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reward- based learning</keyword>
  <keyword>Pavlovian-to-instrumental transfer</keyword>
  <keyword>Functional imaging</keyword>
  <keyword>Relapse risk</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

